Composed of robust fetal bovine collagen, PriMatrix® is an acellular matrix designed to support cellular repopulation and revascularization in various clinical applications. It has demonstrated clinical success regardless of wound type, location, size or complexity, in diverse operative settings and for a wide spectrum of patients.  This adaptability makes it an excellent choice to treat a wide range of surgically challenging wounds.

In this webinar, a panel of clinicians highlight their use of PriMatrix® around the adaptability of the technology. Their surgical indications include cases of large necrotizing fasciitis wounds, extremity trauma cases, and large surface area burn wounds.

The discussion is moderated by Peter Arnold, M.D., Ph.D., Professor and Chief of Plastic & Reconstructive Surgery, University of Mississippi.

Panelists include:

Nicole Kopari, M.D., F.A.C.S.
Assistant Medical Director
Leon S. Peters Burn Center
UCSF Fresno Community Medical Center
Fresno, CA

Suhail Mithani, M.D.
Associate Professor Plastic and Orthopaedic Surgery
Duke University Medical Center

Rohit Mittal, M.D.
Assistant Professor of Surgery
Emory University School of Medicine
Grady Memorial Hospital
Grady Burn Center

 

Indications

PriMatrix® is intended for the management of wounds that include:

  • Partial and full thickness wounds
  • Pressure, diabetic, and venous ulcers
  • Second-degree burns
  • Surgical wounds—donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence
  • Trauma wounds —abrasions, lacerations and skin tears
  • Tunneled/undermined wounds
  • Draining wounds

Contraindications

  • PriMatrix® should not be used for patients with a known history of hypersensitivity to
    collagen or bovine products.

Warning and Precautions

  • PriMatrix should be used with caution in regions where an infection exists or is suspected. Treat any existing infection appropriately.
  • PriMatrix should not be applied directly on third-degree burns.